Inhalation Aerosol to three inner-city clinics in New York City for use with the clinics asthma patients. Clinic patients for whom Flovent is determined to be an appropriate asthma medication, will be provided a free 30-day supply of Flovent. If a patient affected by this recall is unable to replace the Vanceril brand inhaler with the same medicine, clinic physicians will have another alternative available for patients at no cost to the patient. Participants in the program will meet with clinic staff to discuss their current asthma management plan. Introduced in 1996, Flovent has become the world s leading brand of inhaled anti-inflammatory medication.
Corticosteroids are natural substances found in the body that fight inflammation.
Corticosteroids are used to treat asthma because they help reduce swelling and irritation in the walls of the small airway passages and help ease breathing problems. When taken regularly, corticosteroids also help prevent asthma symptoms. We re pleased that through this program we can provide additional information about asthma management to our patients and help ensure that they have continued access to this type of maintenance medication. Flovent Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy for patients 12 years of age and older. Flovent Inhalation Aerosol is NOT indicated for the relief of acute bronchospasm.